Related Experiment Video
Updated: Jun 17, 2026
09:15
Combining X-Ray Crystallography with Small Angle X-Ray Scattering to Model Unstructured Regions of Nsa1 from S. Cerevisiae
Published on: January 10, 2018
X-ray structures of NS1 effector domain mutants
Shuangluo Xia1, Jon D Robertus
1Institute for Cellular and Molecular Biology, Department of Chemistry and Biochemistry, University of Texas, 1 University Station A5300, Austin, TX 78712, USA.
Archives of Biochemistry and Biophysics
|December 10, 2009
Summary
Influenza A virus NS1 protein mutants were studied. A monomeric mutant (W187Y) retains binding to CPSF30, offering a new target for antiviral drug development.
Area of Science:
- Virology
- Structural Biology
- Drug Discovery
Background:
- Influenza A virus nonstructural protein 1 (NS1) is a key viral antagonist of the host immune response.
- The NS1 C-terminal effector domain interacts with host factors like CPSF30 and is a target for antiviral therapies.
Purpose of the Study:
- To characterize the structural and binding properties of NS1 effector domain mutants.
- To explore the potential of monomeric NS1 mutants as drug targets.
Main Methods:
- Crystallography to determine protein structures.
- Gel filtration and light scattering to assess protein behavior in solution.
- Binding assays to measure affinity to CPSF30.
Main Results:
- Two NS1 effector domain mutants (W187Y, W187A) were generated from influenza A/Udorn/72.
- Mutants exhibited monomeric behavior in solution, unlike the wild-type dimeric form.
- The W187Y mutant maintained high binding affinity to CPSF30, similar to wild-type.
Conclusions:
- Monomeric NS1 mutants, specifically W187Y, retain essential binding capabilities.
- The accessible, unoccupied binding pocket of monomeric NS1 makes it a promising candidate for high-throughput screening of antiviral inhibitors.
